Nabi Zaheer, Ramchandani Mohan, Chavan Radhika, Kalapala Rakesh, Darisetty Santosh, Rao Guduru Venkat, Reddy Nageshwar
Asian Institute of Gastroenterology - Gastroenterology, Hyderabad, India.
Asian Institute of Gastroenterology - Anaestheisa, Hyderabad, India.
Endosc Int Open. 2017 May;5(5):E331-E339. doi: 10.1055/s-0043-105517.
Per-oral endoscopic myotomy (POEM) has emerged as an efficacious treatment modality for the management of achalasia cardia (AC) and non-achalasia spastic esophageal motility disorders. Initial results are encouraging. We analyzed the safety and efficacy of POEM in a large cohort of patients with AC. The data from patients who underwent POEM (from January 2013 to June 2016) was prospectively collected and analyzed. Clinical success was defined as Eckardt score ≤ 3 after POEM procedure. Objective parameters including high-resolution manometry (HRM) and timed barium swallow (TBS) were analyzed and compared before and after the procedure. Gastroesophageal reflux was analyzed using 24-hour pH impedance study and esophagogastro-duodenoscopy. A total of 408 patients (mean age 40 years, range 4 - 77 years) underwent POEM during the specified period. POEM could be successfully completed in 396 (97 %) patients. Clinical success rates at 1, 2 and 3 years were 94 %, 91 % and 90 %, respectively. Mean Eckardt score was 7.07 ± 1.6 prior to POEM and 1.27 ± 1.06 after POEM ( = 0.001) at 1 year. Significant improvement in esophageal emptying on TBE (> 50 %) was documented in 93.8 % patients who completed 1-year follow up. Pre-procedure and post-procedure mean lower esophageal sphincter pressure was 45 ± 16.5 mmHg and 15.6 ± 6.1 mmHg, respectively ( = 0.001). Technical and clinical success were comparable in naïve vs prior treated cases (97.3 % vs 96.8 %, = 0.795) (95.7 % vs 92.6 %, = 0.275). GERD was documented in 28.3 % patients with 24-hour pH-impedance study and erosive esophagitis was seen in 18.5 % of patients who underwent POEM. POEM is safe, effective and has a durable response in patients with achalasia cardia. Prior treatment does not influence the outcomes of POEM.
经口内镜下肌切开术(POEM)已成为治疗贲门失弛缓症(AC)和非失弛缓性痉挛性食管动力障碍的一种有效治疗方式。初步结果令人鼓舞。我们分析了POEM在一大群AC患者中的安全性和有效性。前瞻性收集并分析了2013年1月至2016年6月接受POEM治疗患者的数据。临床成功定义为POEM术后埃卡德特评分≤3分。分析并比较了手术前后包括高分辨率测压(HRM)和定时吞钡检查(TBS)在内的客观参数。使用24小时pH阻抗监测和食管胃十二指肠镜检查分析胃食管反流情况。在指定期间共有408例患者(平均年龄40岁,范围4 - 77岁)接受了POEM治疗。396例(97%)患者成功完成了POEM手术。1年、2年和3年的临床成功率分别为94%、91%和90%。1年时,POEM术前平均埃卡德特评分为7.07±1.6,术后为1.27±1.06(P = 0.001)。在完成1年随访的患者中,93.8%的患者TBS显示食管排空有显著改善(>50%)。术前和术后食管下括约肌平均压力分别为45±16.5mmHg和15.6±6.1mmHg(P = 0.001)。初治患者与既往治疗患者的技术成功率和临床成功率相当(97.3%对96.8%,P = 0.795)(95.7%对92.6%,P = 0.275)。24小时pH阻抗监测显示28.3%的患者存在胃食管反流病,接受POEM治疗的患者中18.5%出现糜烂性食管炎。POEM对贲门失弛缓症患者安全、有效且疗效持久。既往治疗不影响POEM的治疗效果。